Potentially inappropriate medications among older patients with Parkinson’s disease: a cross-sectional analysis of a national health insurance database in China
Mengyuan Fu, Can Li, Zinan Zhao, Kexin Ling, Zhiwen Gong, Huangqianyu Li, Ting Li, Jianchun Li, Weihang Cao, Xin Hu, Luwen Shi, Pengfei Jin, Xiaodong Guan · 2023
Read Potentially inappropriate medications among older patients with Parkinson’s disease: a cross-sectional analysis of a national health insurance database in China by Mengyuan Fu, Can Li, Zinan Zhao, Kexin Ling, Zhiwen Gong, Huangqianyu Li, Ting Li, Jianchun Li, Weihang Cao, Xin Hu, Luwen Shi, Pengfei Jin, Xiaodong Guan (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10709967.txt.
Description
Mengyuan Fu and twelve co-authors count risky drug use in older Parkinson's patients in China in a 2023 paper. Some drugs harm older adults more than they help. Parkinson's patients have complex drug needs across motor and mind symptoms. How often risky drugs reach them in China was unknown.
The team read a national insurance database from 2015 to 2017. It held 14,452 patients aged 65 and over with the disease. About 58 percent got at least one risky drug in that span. About 43 percent got a drug that can dull the mind. Use rose with age and ran higher in women. Younger patients got more motor-risk drugs, though. The authors urge targeted work on safer prescribing.
Catalog record
| CREATOR | Mengyuan Fu, Can Li, Zinan Zhao, Kexin Ling, Zhiwen Gong, Huangqianyu Li, Ting Li, Jianchun Li, Weihang Cao, Xin Hu, Luwen Shi, Pengfei Jin, Xiaodong Guan |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |